An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery. Methods: From 2006 to 2010, patients on anti-TB treatment were ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

TB is treated with antibiotics that must be taken for at least six months. Modern anti-TB drugs are extremely effective and, in nearly all cases, sufferers feel much better after the first two ...

NPPA issues draft calculation sheet for nine scheduled formulations: Gireesh Babu, New Delhi Tuesday, April 15, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing Authority ...

Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...

The Trump-Kennedy program to slash HHS funding threatens global health, scientific progress, and the lives of millions of ...